Literature DB >> 29657127

The Intestinal Microbiota in Colorectal Cancer.

Herbert Tilg1, Timon E Adolph2, Romana R Gerner3, Alexander R Moschen3.   

Abstract

Experimental evidence from the past years highlights a key role for the intestinal microbiota in inflammatory and malignant gastrointestinal diseases. Diet exhibits a strong impact on microbial composition and provides risk for developing colorectal carcinoma (CRC). Large metagenomic studies in human CRC associated microbiome signatures with the colorectal adenoma-carcinoma sequence, suggesting a fundamental role of the intestinal microbiota in the evolution of gastrointestinal malignancy. Basic science established a critical function for the intestinal microbiota in promoting tumorigenesis. Further studies are needed to decipher the mechanisms of tumor promotion and microbial co-evolution in CRC, which may be exploited therapeutically in the future.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  bacteria; cancer; immunity; inflammation; microbiota

Mesh:

Year:  2018        PMID: 29657127     DOI: 10.1016/j.ccell.2018.03.004

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  184 in total

1.  Mucosal cancer-associated microbes and anastomotic leakage after resection of colorectal carcinoma.

Authors:  Kosuke Mima; Yuki Sakamoto; Keisuke Kosumi; Yoko Ogata; Keisuke Miyake; Yukiharu Hiyoshi; Takatsugu Ishimoto; Masaaki Iwatsuki; Yoshifumi Baba; Shiro Iwagami; Yuji Miyamoto; Naoya Yoshida; Shuji Ogino; Hideo Baba
Journal:  Surg Oncol       Date:  2019-11-18       Impact factor: 3.279

2.  In Vitro and In Vivo Activities of Zinc Linolenate, a Selective Antibacterial Agent against Helicobacter pylori.

Authors:  Yanqiang Huang; Xudong Hang; Xueqing Jiang; Liping Zeng; Jia Jia; Yong Xie; Fei Li; Hongkai Bi
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

Review 3.  Prebiotics: tools to manipulate the gut microbiome and metabolome.

Authors:  Fatima Enam; Thomas J Mansell
Journal:  J Ind Microbiol Biotechnol       Date:  2019-06-14       Impact factor: 3.346

Review 4.  Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome-driven neoplasms.

Authors:  Tsuyoshi Hamada; Jonathan A Nowak; Danny A Milner; Mingyang Song; Shuji Ogino
Journal:  J Pathol       Date:  2019-02-20       Impact factor: 7.996

5.  Gut microbiome-immune crosstalk affects progression of cancer.

Authors:  Herbert Tilg; Andreas Schmiderer; Angela Djanani
Journal:  Transl Gastroenterol Hepatol       Date:  2018-06-19

Review 6.  Comprehensive review of targeted therapy for colorectal cancer.

Authors:  Yuan-Hong Xie; Ying-Xuan Chen; Jing-Yuan Fang
Journal:  Signal Transduct Target Ther       Date:  2020-03-20

Review 7.  Environmental Factors, Gut Microbiota, and Colorectal Cancer Prevention.

Authors:  Mingyang Song; Andrew T Chan
Journal:  Clin Gastroenterol Hepatol       Date:  2018-07-18       Impact factor: 11.382

Review 8.  Enteric Virome and Carcinogenesis in the Gut.

Authors:  Cade Emlet; Mack Ruffin; Regina Lamendella
Journal:  Dig Dis Sci       Date:  2020-03       Impact factor: 3.199

9.  Structure of the Mucosal and Stool Microbiome in Lynch Syndrome.

Authors:  Yan Yan; David A Drew; Arnold Markowitz; Jason Lloyd-Price; Galeb Abu-Ali; Long H Nguyen; Christina Tran; Daniel C Chung; Katherine K Gilpin; Dana Meixell; Melanie Parziale; Madeline Schuck; Zalak Patel; James M Richter; Peter B Kelsey; Wendy S Garrett; Andrew T Chan; Zsofia K Stadler; Curtis Huttenhower
Journal:  Cell Host Microbe       Date:  2020-04-01       Impact factor: 21.023

10.  The Wnt-β-Catenin-IL-10 Signaling Axis in Intestinal APCs Protects Mice from Colitis-Associated Colon Cancer in Response to Gut Microbiota.

Authors:  Daniel Swafford; Arulkumaran Shanmugam; Punithavathi Ranganathan; Indumathi Manoharan; Mohamed S Hussein; Nikhil Patel; Humberto Sifuentes; Pandelakis A Koni; Puttur D Prasad; Muthusamy Thangaraju; Santhakumar Manicassamy
Journal:  J Immunol       Date:  2020-09-11       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.